Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2718903 | 0.81 | KHK (0.31) | ALDH1A1CYP3A4 | |
| SCHEMBL24629868 | 0.79 | GAA (0.31) | — | |
| SCHEMBL16727102 | 0.79 | — | — | |
| SCHEMBL30777276 | 0.77 | ALDH1A1 (0.38) | ALDH1A1CYP3A4 | |
| SCHEMBL836469 | 0.76 | CA1 (0.40) | — | |
| SCHEMBL1415606 | 0.74 | ACACB (0.39) | ALDH1A1CYP3A4 | |
| SCHEMBL31326225 | 0.74 | ACACB (0.39) | ALDH1A1CYP3A4 | |
| SCHEMBL20929233 | 0.73 | ALDH1A1 (0.41) | ALDH1A1CYP3A4 | |
| SCHEMBL30499834 | 0.73 | GRM5 (0.40) | ALDH1A1CYP3A4 | |
| SCHEMBL14092885 | 0.72 | KDM4E (0.30) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8741942-B2 | Inhibitors of cellular necrosis | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-06-03 | — | — | US | disclosed |
| US-20120149702-A1 | INHIBITORS OF CELLULAR NECROSIS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2012-06-14 | — | — | US | disclosed |
| US-8143300-B2 | Inhibitors of cellular necrosis | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-03-27 | — | — | US | disclosed |
| US-20110144169-A1 | Inhibitors of cellular necrosis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144169-A1 | Inhibitors of cellular necrosis | TNF, AIFM1, BAD | ALDH1A1 2543/4885CYP3A4 4860/4885 |
| US-20120149702-A1 | INHIBITORS OF CELLULAR NECROSIS | TNF, AIFM1, BAD | ALDH1A1 2543/4885CYP3A4 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.